A Randomized, Double-blind, Placebo-controlled Study of Proteoglycan and Phosphatidylserine for Management of Knee and Hip Pain

Poul Aage Hansen MD

Geriatric Rehabilitation Clinic, Nässjö, Sweden.

Nicoline Stampe Buchard Hønnerup

Well-Come Fitness & Health Center, Copenhagen, Denmark.

Kari-Nina Sprunk-Jansen *

CaKel Aps, Copenhagen, Denmark.

*Author to whom correspondence should be addressed.


Abstract

Aims: This study was designed to evaluate if combined oral administration of proteoglycan and phosphatidylserine (PG+PS) for 30 days would improve osteoarthritis symptoms in adults with moderate to severe knee and hip pain.

Study Design:  Randomized, double-blind, placebo-controlled study.

Place and Duration of Study: Well-Come Fitness & Health Center (Copenhagen, Denmark), between September 2023 to November 2023.

Methodology: A total of 96 participants (65 female, 31 male, mean age 51 years, mean body mass index 25 kg/m2) were randomized to take 1 tablet/day of placebo (N=31), 12.5 mg proteoglycan (PG, N=32), or 12.5 mg proteoglycan + 60 mg phosphatidylserine (PG+PS, N=33) orally for 30 days. The change from baseline in physical performance was evaluated by stair climb test (SCT) and self-paced walk test (SPWT). Joint (knee and hip) pain prior to physical performance tests was evaluated by the change in visual analog scale (VAS) score (range 0-10).

Results: Statistically significant improvements were observed in the change from baseline to Day 30 for the SCT and SPWT for PG+PS vs placebo and PG+PS vs PG (all P < .05). Statistically significant improvements in joint pain (VAS Score) were also observed for PG+PS vs placebo and vs PG. Improvements in physical performance and joint pain with PG+PS generally occurred during the first week of the study.

Conclusion: Combination administration of PG+PS for 30 days reduced joint pain and improved physical performance in adults with moderate to severe knee and hip pain. Additional studies to further validate these findings are warranted.

Keywords: Phosphatidylserine, proteoglycan, knee, hip pain, healthy joint mobility, endurance


How to Cite

Hansen MD, Poul Aage, Nicoline Stampe Buchard Hønnerup, and Kari-Nina Sprunk-Jansen. 2024. “A Randomized, Double-Blind, Placebo-Controlled Study of Proteoglycan and Phosphatidylserine for Management of Knee and Hip Pain”. Current Journal of Applied Science and Technology 43 (6):187-94. https://doi.org/10.9734/cjast/2024/v43i64400.

Downloads

Download data is not yet available.

References

Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020; 79(6):819-828. DOI: 10.1136/annrheumdis-2019-216515.

Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. E clinical Medicine. 2020;29-30:100587. DOI: 10.1016/j.eclinm.2020.100587.

Vina ER, Kwoh CK. Epidemiology of osteoarthritis: Literature update. Curr Opin Rheumatol. 2018;30(2):160- 167.

DOI: 10.1097/BOR.0000000000000479.

Alcaide-Ruggiero L, Cugat R, Dominguez JM. Proteoglycans in articular cartilage and their contribution to chondral injury and repair mechanisms. Int J Mol Sci. 2023; 24(13). DOI: 10.3390/ijms241310824.

Alberton P, Dugonitsch HC, Hartmann B, Li P, Farkas Z, Saller MM, et al. Aggrecan hypomorphism compromises articular cartilage biomechanical properties and is associated with increased incidence of spontaneous osteoarthritis. Int J Mol Sci. 2019;20(5). DOI: 10.3390/ijms20051008.

Marouf BH. Effect of resveratrol on serum levels of type ii collagen and aggrecan in patients with knee osteoarthritis: A pilot clinical study. Biomed Res Int. 2021; 2021:3668568. DOI: 10.1155/2021/3668568.

Henrotin Y, Marty M, Mobasheri A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas. 2014;78(3):184-7. DOI: 10.1016/j.maturitas.2014.04.015.

Yoshimura S, Asano K, Nakane A. Attenuation of collagen-induced arthritis in mice by salmon proteoglycan. Biomed Res Int. 2014;2014:406453. DOI: 10.1155/2014/406453.

Tomonaga A, Takahashi T, Tanaka YT, Tsuboi M, Ito K, Nagaoka I. Evaluation of the effect of salmon nasal proteoglycan on biomarkers for cartilage metabolism in individuals with knee joint discomfort: A randomized double-blind placebo-controlled clinical study. Exp Ther Med. 2017;14(1):115-126. DOI: 10.3892/etm.2017.4454.

Naraoka Y, Harada H, Katagiri M, Yamamura H, Shirasawa T. N-acetyl glucosamine and proteoglycan containing supplement improves the locomotor functions of subjects with knee pain. Drug Discov Ther. 2017;11(3):140-145.

DOI: 10.5582/ddt.2017.01019.

Ma X, Li X, Wang W, Zhang M, Yang B, Miao Z. Phosphatidylserine, inflammation, and central nervous system diseases. Front Aging Neurosci. 2022; 14:975176.

DOI: 10.3389/fnagi.2022.975176.

Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000;405 (6782):85-90. DOI: 10.1038/35011084.

Hoffmann PR, Kench JA, Vondracek A, Kruk E, Daleke DL, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses In vivo. J Immunol. 2005;174(3):1393- 404.

DOI: 10.4049/jimmunol.174.3.1393.

Ma HM, Wu Z, Nakanishi H. Phosphatidylserine-containing liposomes suppress inflammatory bone loss by ameliorating the cytokine imbalance provoked by infiltrated macrophages. Lab Invest. 2011;91(6):921-31.

DOI: 10.1038/labinvest.2011.54.

Cruz MAE, Ferreira CR, Tovani CB, de Oliveira FA, Bolean M, Caseli L, et al. Phosphatidylserine controls calcium phosphate nucleation and growth on lipid monolayers: A physicochemical understanding of matrix vesicle-driven biomineralization. J Struct Biol. 2020; 212(2):107607. DOI: 10.1016/j.jsb.2020.107607.

More MI, Freitas U, Rutenberg D. Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia. Adv Ther. 2014;31(12):1247-62. DOI: 10.1007/s12325-014-0165-1.

Hellhammer J, Vogt D, Franz N, Freitas U, Rutenberg D. A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: A randomized, placebo-controlled study. Lipids Health Dis 2014; 13:121. DOI: 10.1186/1476-511X-13-121.

Vakhapova V, Cohen T, Richter Y, Herzog Y, Kam Y, Korczyn AD. Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: Results from an open-label extension study. Dement Geriatr Cogn Disord. 2014;38(1-2):39- 45. DOI: 10.1159/000357793.

Wells AJ, Hoffman JR, Gonzalez AM, Stout JR, Fragala MS, Mangine GT, et al. Phosphatidylserine and caffeine attenuate postexercise mood disturbance and perception of fatigue in humans. Nutr Res. 2013;33(6):464-72.

DOI: 10.1016/j.nutres.2013.03.009.

Hellhammer J, Hero T, Franz N, Contreras C, Schubert M. Omega-3 fatty acids administered in phosphatidylserine improved certain aspects of high chronic stress in men. Nutr Res. 2012;32(4):241-50.

DOI: 10.1016/j.nutres.2012.03.003.

Baumeister J, Barthel T, Geiss KR, Weiss M. Influence of phosphatidylserine on cognitive performance and cortical activity after induced stress. Nutr Neurosci. 2008; 11(3):103-10.

DOI: 10.1179/147683008X301478.

Bennell K, Dobson F, Hinman R. Measures of physical performance assessments: Self-Paced Walk Test (SPWT), Stair Climb Test (SCT), Six-Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task. Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S350-70. DOI: 10.1002/acr.20538.

Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 2001;18(3):205-7. DOI: 10.1136/emj.18.3.205.